PIR and lung carcinoma: Overexpression of piR-35127 and piR-46545 and knockdown of piR-34871 and piR-52200 significantly reduced cell proliferation in both lung cancer cell lines (A549 and H1299) and breast cancer cell lines (Hs578T and MDA-MB-231) (18).